clinical trial diversity

ESG Ratings FAQs: The Process, Rating Levels, and Reason Why They Matter

ESG Rating FAQs: The Process, Rating Levels, and Reasons Why They Matter

EcoVadis, the leading global supply chain environmental, ethical, and social performance ratings platform, recently awarded Clincierge a Bronze rating. This score places Clincierge in the top 50% of all companies evaluated by EcoVadis. Clincierge Earns Bronze Sustainability Rating from EcoVadis Clincierge was recognized for the following in this inaugural business review: Commitment to employee diversity …

ESG Rating FAQs: The Process, Rating Levels, and Reasons Why They Matter Read More »

ESG Ratings FAQs: The Process, Rating Levels, and Reason Why They Matter

Clincierge Earns Bronze Sustainability Rating from EcoVadis

PHILADELPHIA, Feb. 23, 2023 /PRNewswire/ — Clincierge, a patient concierge services provider in clinical trials, was recently awarded a Bronze rating from EcoVadis, the leading platform for environmental, social, and ethical performance ratings for global supply chains. This rating places Clincierge higher than 50% of global companies within the same industry and recognizes their positive environmental, social, …

Clincierge Earns Bronze Sustainability Rating from EcoVadis Read More »

Health Equity and DEI: Are They Synonymous?

Health Equity and DEI: Are They Synonymous?

Due to a lack of health equity and many existing health disparities for rare disease patients, their access to clinical trial participation is often greatly diminished. With limited education and finances, many do not know about trial opportunities, while others cannot fathom the additional costs of participating.

Drug discovery predictions: Analysis and insight

Drug Discovery Predictions: Analysis and Insight

In this Drug Discovery World article, author Megan Thomas spoke with decision makers from the clinical trial industry, including Clincierge’s CEO, Scott Gray, about their predictions on what 2022 holds for our sector, including the importance of patient-centricity and improved stakeholder engagement in clinical trials.

Amplifying the Patient Voice to Build More Inclusive Clinical Trials

Outlook 2023: Amplifying the Patient Voice to Build More Inclusive Clinical Trials

Clincierge CEO Scott Gray was recently featured in Citeline’s 2023 Outlook. This annual publication showcases industry thought leaders and forecasts market trends within the clinical trial industry. Amplifying the Patient Voice to Build More Inclusive Clinical Trials His piece in Outlook 2023 entitled Amplifying the Patient Voice to Build More Inclusive Clinical Trials discusses ways …

Outlook 2023: Amplifying the Patient Voice to Build More Inclusive Clinical Trials Read More »

CISCRP Patient Diversity Campaign

CISCRP: Supporting Patient Diversity Campaign 2022

Clincierge is proud to support CISCRP in a new educational initiative to increase awareness about clinical research and the level of understanding among minority communities across the U.S.We have united to circulate an informative full-page advertorial spread highlighting the key importance of diversity in clinical studies to discover treatments that are effective for everyone.

SCRS_INSITE_AMPLIFYING_THE_VOICE_OF_THE_PATIENT_IN_RARE_DISEASE_TRIALS

Amplifying the Voice of the Patient in Rare Disease Trials

Featured in SCRS InSite Journal: Scott Gray, CEO, discusses patient recruitment and retention, two of the most pressing challenges facing clinical research today. Continue reading to learn more about understanding the financial, logistical, and emotional barriers to participation, the consequences of poor retention and enrollment, actionable steps to improve trial outcomes, and other key findings …

Amplifying the Voice of the Patient in Rare Disease Trials Read More »

Voice of the Patient Research

View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.

Voice of the patient